Sutter Health:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Sutter Health - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11491
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Sutter Health (Sutter Health) is a non-profit healthcare service provider, which provides health care service through its hospitals, ambulatory surgery centers, cardiac centers, cancer centers, rehabilitation centers and others. It serves communities across Northern California- in the San Francisco Bay Area, the Central Valley, the Sacramento region and the northern and southern coastal areas. The organization also offers services in other areas, including Hawaii and Southern California. Sutter Health offers carries out transplants, advanced treatments for cancer and surgical techniques and delivery services. Its affiliated and aligned doctors, hospitals and specialty care centers partner to provide patients medical care personalized to their needs. Sutter Health is headquartered in Sacramento, California, the US.

Sutter Health – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Sutter Health, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sutter Health, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sutter Health, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sutter Health, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Sutter Health, Medical Devices Deals, 2012 to YTD 2018 9
Sutter Health, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Sutter Health, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
BrainStorm Cell Therapeutics Enters into Agreement with Massachusetts General Hospital and California Pacific Medical Center 11
Boehringer Ingelheim Pharma Enters into Research Agreement with Sutter Health 12
AstraZeneca Enters into Research Agreement with Sutter Health 13
Licensing Agreements 14
Insys Therapeutics Enters into Licensing Agreement with California Pacific Medical Center Research Institute 14
Debt Offering 15
Sutter Health Plans Public Offering Of Bonds For US$450 Million 15
Sutter Health Plans Public Offering Of Bonds For US$300 Million 16
Asset Transactions 17
Alameda Health System Completes Acquisition Of San Leandro Hospital From Sutter Health 17
Sutter Health – Key Competitors 18
Sutter Health – Key Employees 19
Sutter Health – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 22
Other Significant Developments 22
Jan 18, 2018: Sutter Health Improves Asthma Pilot Program by Expanding Telemedicine 22
Oct 17, 2017: Sutter Santa Rosa Regional Hospital to Re-Open Tuesday 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
Sutter Health, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Sutter Health, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sutter Health, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sutter Health, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sutter Health, Deals By Therapy Area, 2012 to YTD 2018 8
Sutter Health, Medical Devices Deals, 2012 to YTD 2018 9
Sutter Health, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
BrainStorm Cell Therapeutics Enters into Agreement with Massachusetts General Hospital and California Pacific Medical Center 11
Boehringer Ingelheim Pharma Enters into Research Agreement with Sutter Health 12
AstraZeneca Enters into Research Agreement with Sutter Health 13
Insys Therapeutics Enters into Licensing Agreement with California Pacific Medical Center Research Institute 14
Sutter Health Plans Public Offering Of Bonds For US$450 Million 15
Sutter Health Plans Public Offering Of Bonds For US$300 Million 16
Alameda Health System Completes Acquisition Of San Leandro Hospital From Sutter Health 17
Sutter Health, Key Competitors 18
Sutter Health, Key Employees 19
Sutter Health, Subsidiaries 20

List of Figures
Sutter Health, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Sutter Health, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Sutter Health, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Sutter Health, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Sutter Health, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sutter Health, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Sutter Health, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sutter Health, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Sutter Health, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Sutter Health:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Martin Midstream Partners LP (MMLP):石油・ガス:M&Aディール及び事業提携情報
    Summary Martin Midstream Partners LP (Martin Midstream) is a midstream service provider that carries out the transportation, storage and distribution of petroleum products and by-products. Its service offerings include terminalling, transportation, distribution, and midstream logistical services, be …
  • Denison Mines Corp (DNN):企業の財務・戦略的SWOT分析
    Denison Mines Corp (DNN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Chongqing Taiji Industry (Group) Co Ltd (600129):製薬・医療:M&Aディール及び事業提携情報
    Summary Chongqing Taiji Industry (Group) Co Ltd (Chongqing Taiji) is a provider of generic products. The company offers products such as traditional Chinese medicine, hospital products, OTC products, base products, and dietary supplement. It provides research and development, equipment, and manageme …
  • Pacgen Life Science Corp (PBS):企業の財務・戦略的SWOT分析
    Summary Pacgen Life Science Corp (Pacgen), formerly Pacgen Biopharmaceuticals Corp, is a life science technology company that develops and commercializes biomedical products and services. The company offers development of novel therapeutic drug candidates. It provides product such as include amino-a …
  • AIMM Therapeutics BV-製薬・医療分野:企業M&A・提携分析
    Summary AIMM Therapeutics BV (AIMM Therapeutics) is a biotechnology company that develops progressive approach to the discovery of therapeutic antibodies for the treatment of cancer and infectious diseases. The company offers research programs for prevention and treatment of diseases with medical ne …
  • Align Technology, Inc.:企業の戦略・SWOT・財務情報
    Align Technology, Inc. - Strategy, SWOT and Corporate Finance Report Summary Align Technology, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • SEAKR Engineering, Inc.:企業の戦略・SWOT・財務情報
    SEAKR Engineering, Inc. - Strategy, SWOT and Corporate Finance Report Summary SEAKR Engineering, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Cevec Pharmaceuticals GmbH:企業のM&A・事業提携・投資動向
    Cevec Pharmaceuticals GmbH - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Cevec Pharmaceuticals GmbH Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Mediolanum farmaceutici SpA-製薬・医療分野:企業M&A・提携分析
    Summary Mediolanum farmaceutici SpA (Mediolanum) is a healthcare solution provider that discovers, develops and markets pharmaceuticals products and prescription drugs. The company offers products in therapeutic areas which include neuropsychiatric, osteoarticular, antibiotic, pneumoallergological, …
  • Realtek Semiconductor Corp. (2379):企業の財務・戦略的SWOT分析
    Realtek Semiconductor Corp. (2379) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • GW Pharmaceuticals Plc (GWP)-医療機器分野:企業M&A・提携分析
    Summary GW Pharmaceuticals plc (GW Pharmaceuticals) is a biopharmaceutical company which discovers, develops and commercializes innovative therapeutics from its proprietary cannabinoid product platform. The company’s commercialized product, Sativex is a plant-derived cannabinoid prescription drug, f …
  • Mobidiag Ltd:企業の製品パイプライン分析
    Summary Mobidiag Ltd (Mobidiag) operates as a biotechnology company that develops and markets products for molecular diagnosis of infectious diseases and test kits. The company's products portfolio includes Novodiag, Amplidiag, and Prove-it. Its Amplidiag is a diagnostic test for high-volume screeni …
  • Dino Polska S.A (DNP):企業の財務・戦略的SWOT分析
    Dino Polska S.A (DNP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Provectus Biopharmaceuticals Inc (PVCT):企業の財務・戦略的SWOT分析
    Summary Provectus Biopharmaceuticals Inc (Provectus) is a developer of pharmaceuticals for oncology and dermatology indications. The company provides pipeline products such as PV-10 for locally advanced cutaneous melanoma, PV-10 for metastatic liver cancer and PV-10 for neuroendocrine tumors [NET], …
  • Ajanta Pharma Ltd (AJANTPHARM):企業の財務・戦略的SWOT分析
    Ajanta Pharma Ltd (AJANTPHARM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • STMicroelectronics NV (STM):企業の財務・戦略的SWOT分析
    STMicroelectronics NV (STM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • DPL Inc. (DPL):電力:M&Aディール及び事業提携情報
    Summary DPL Inc. (DPL) a subsidiary of AES Corporation is a diversified energy and utility company. It is engaged in the generation, transmission and distribution of electricity in West Central Ohio. The company provides its services to residential, commercial, and industrial and government customer …
  • Oki Electric Industry Co., Ltd. (6703):企業の財務・戦略的SWOT分析
    Oki Electric Industry Co., Ltd. (6703) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Banco BPM S.p.A.:企業の戦略・SWOT・財務分析
    Banco BPM S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Banco BPM S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Nathan’s Famous, Inc. (NATH):企業の財務・戦略的SWOT分析
    Nathan's Famous, Inc. (NATH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆